当前位置: X-MOL 学术Nat. Rev. Nephrol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations
Nature Reviews Nephrology ( IF 41.5 ) Pub Date : 2021-05-10 , DOI: 10.1038/s41581-021-00423-5
Heidi Noels 1, 2 , Michael Lehrke 3 , Raymond Vanholder 4 , Joachim Jankowski 1, 5
Affiliation  

Chronic kidney disease (CKD) induces modifications in lipid and lipoprotein metabolism and homeostasis. These modifications can promote, modulate and/or accelerate CKD and secondary cardiovascular disease (CVD). Lipid and lipoprotein abnormalities — involving triglyceride-rich lipoproteins, LDL and/or HDL — not only involve changes in concentration but also changes in molecular structure, including protein composition, incorporation of small molecules and post-translational modifications. These alterations modify the function of lipoproteins and can trigger pro-inflammatory and pro-atherogenic processes, as well as oxidative stress. Serum fatty acid levels are also often altered in patients with CKD and lead to changes in fatty acid metabolism — a key process in intracellular energy production — that induce mitochondrial dysfunction and cellular damage. These fatty acid changes might not only have a negative impact on the heart, but also contribute to the progression of kidney damage. The presence of these lipoprotein alterations within a biological environment characterized by increased inflammation and oxidative stress, as well as the competing risk of non-atherosclerotic cardiovascular death as kidney function declines, has important therapeutic implications. Additional research is needed to clarify the pathophysiological link between lipid and lipoprotein modifications, and kidney dysfunction, as well as the genesis and/or progression of CVD in patients with kidney disease.



中文翻译:

慢性肾脏病中的脂蛋白和脂肪酸:分子和代谢改变

慢性肾脏病 (CKD) 诱导脂质和脂蛋白代谢和体内平衡的改变。这些修饰可以促进、调节和/或加速 CKD 和继发性心血管疾病 (CVD)。脂质和脂蛋白异常——涉及富含甘油三酯的脂蛋白、低密度脂蛋白和/或高密度脂蛋白——不仅涉及浓度的变化,还涉及分子结构的变化,包括蛋白质组成、小分子的掺入和翻译后修饰。这些改变改变了脂蛋白的功能,可以触发促炎和促动脉粥样硬化过程,以及氧化应激。CKD 患者的血清脂肪酸水平也经常发生变化,并导致脂肪酸代谢发生变化——细胞内能量产生的一个关键过程——从而导致线粒体功能障碍和细胞损伤。这些脂肪酸的变化不仅可能对心脏产生负面影响,而且还会促进肾脏损伤的进展。在以炎症和氧化应激增加为特征的生物环境中存在这些脂蛋白改变,以及随着肾功能下降而存在非动脉粥样硬化性心血管死亡的竞争风险,具有重要的治疗意义。需要进一步的研究来阐明脂质和脂蛋白修饰与肾功能障碍之间的病理生理学联系,

更新日期:2021-05-11
down
wechat
bug